Convatec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies for the management of chronic conditions in Europe, North America, and internationally. The company offers advanced wound care products for the management of acute and chronic…more
Convatec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies for the management of chronic conditions in Europe, North America, and internationally. The company offers advanced wound care products for the management of acute and chronic…more
Latest RNS from Convatec Group PLC
- board_changeCFO succession and NED appointment
- holdingsHolding(s) in Company
Analyst consensus: Buy
As of 22 Jul 2026, 18 analysts rate Convatec Group PLC a Buy, with 94% buy ratings and a mean price target of 298p (range 228p–371p), +39% vs the current price.
Valuation vs peers
Peer-relative fair value estimate: 195p against a current price of 214p (-9%), based on EV/EBITDA.